3rd Place: Prevalence of Anxiety, Depression, and Attention Deficit Disorder in Patients with Primary Hyperhidrosis

Main Article Content

Ella Glaser
University of Miami Miller School of Medicine

King Rosemary
University of Miami Miller School of Medicine

Dee Anna Glaser
Saint Louis University

Keywords

psychodermatology, hyperhidrosis

Abstract

Abstract not available. 

References

1. Doolittle et al. Arch Dermatol Res. 2016;308(10):743-9.

2. Bahar R, Liu Y, Huang Y, et al. The prevalence of anxiety and depression in patients with or
without hyperhidrosis (HH). J Am Acad Dermatol. 2016;75:1126-1133

3. Braganca GM, Lima SO, Pinto Neto AF, Marques LM, Melo EV, Reis FP. Evaluation of
anxiety and depression prevalence in patients with primary severe hyperhidrosis. An Bras
Dermatol. 2014;89:230-235.

4. Weber A, Heger S, Sinkgraven R, Heckmann M, Elsner P, Rzany B. Psychosocial aspects of
patients with focal hyperhidrosis. Marked reduction of social phobia, anxiety and depression
and increased quality of life after treatment with botulinum toxin A. Br J Dermatol.
2005;152:342-345

5. Klein SZ, Hull M, Gillard KK, Peterson-Brandt J. Dermatology and Therapy, 2020;10:1299-
1314

6. Harvard Medical School National Comorbidity Survey (NCS). 2017

7. National Survey on Drug Use and Health (NSDUH) 2019

8. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill
LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM. The prevalence and
correlates of adult ADHD in the United States: results from the National Comorbidity Survey
Replication. Am J Psychiatry. 2006 Apr;163(4):716-23.

Article Sidebar

Poster PDF
Published
May 6, 2022
DOI https://doi.org/10.25251/skin.6.supp.34

Article Details

How to Cite
Glaser, E., Rosemary , K. ., & Glaser, D. A. (2022). 3rd Place: Prevalence of Anxiety, Depression, and Attention Deficit Disorder in Patients with Primary Hyperhidrosis. SKIN The Journal of Cutaneous Medicine, 6(3), s34. https://doi.org/10.25251/skin.6.supp.34
Issue
Vol. 6 No. 3 (2022)
Section
2021 UCB® Resident Poster Competition
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.

Most read articles by the same author(s)